{"SPADE_UN_24395": {"Sequence Information": {"Peptide Name": "KR-12 [F10W]+hBD-2 (36-41)[C2L,P6W]", "Sequence": "KRIVQRIKDWLRKLCKKW", "Sequence Length": 18, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P49913", "uniprotUrl": "http://www.uniprot.org/uniprot/P49913", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}, {"uniprotId": "O15263", "uniprotUrl": "http://www.uniprot.org/uniprot/O15263", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Hybrid derivative of cathelicidin and human beta defensin-2 against Gram-positive bacteria: A novel approach for the treatment of bacterial keratitis.", "Pubmed ID": "34526600", "Reference": "Sci Rep. 2021;11:18304", "Author": "Ting DSJ, Goh ETL, Mayandi V, Busoy JMF, Aung TT, Periayah MH, Nubile M, Mastropasqua L, Said DG, Htoon HM, Barathi VA, Beuerman RW, Lakshminarayanan R, Mohammed I, Dua HS", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/34526600"}, {"Title": "Evaluation of Host Defense Peptide (CaD23)-Antibiotic Interaction and Mechanism of Action: Insights From Experimental and Molecular Dynamics Simulations Studies.", "Pubmed ID": "34690770", "Reference": "Front Pharmacol. 2021;12:731499", "Author": "Ting DSJ, Li J, Verma CS, Goh ETL, Nubile M, Mastropasqua L, Said DG, Beuerman RW, Lakshminarayanan R, Mohammed I, Dua HS", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/34690770"}], "Mass": 2397.97, "PI": 11.13, "Net Charge": 7, "Hydrophobicity": -1.03, "Frequent Amino Acids": "KRI", "Absent Amino Acids": "AEFGHMNOPSTUY", "Basic Residues": 8, "Acidic Residues": 1, "Hydrophobic Residues": 6, "Polar Residues": 12, "Positive Residues": 8, "Negative Residues": 1, "SPADE ID": "SPADE_UN_24395", "Similar Sequences": [{"SPADE_ID": "SPADE_N_03128", "Similarity": 1.0, "Sequence": "LLGDFFRKSKEKIGKEFKRIVQR"}, {"SPADE_ID": "SPADE_N_04252", "Similarity": 1.0, "Sequence": "LLGDFFRKSKEKIGKEFKRIVQRIKD"}, {"SPADE_ID": "SPADE_N_04253", "Similarity": 1.0, "Sequence": "LLGDFFRKSKEKIGKEFKRIVQRIK"}], "Hemolytic Activity": "Human corneal epithelial cells HCE-2:50% Cell death=54.6 µg/ml,Human erythrocytes:50% Hemolysis=>200 µg/ml,Human erythrocytes:7.1% Hemolysis=200 µg/ml,Human corneal epithelial cells HCE-2:69.6% Killing=200 µg/ml", "Target Organism": "Staphylococcus aureus SH1000(MIC=12.5µg/ml),Staphylococcus aureus SH1000(MIC=25µg/ml),Staphylococcus aureus ATCC 29213(MIC=25µg/ml),Staphylococcus aureus ATCC 29213(MIC=50µg/ml),Staphylococcus aureus(MIC=25µg/ml),Staphylococcus aureus(MIC=100µg/ml),Staphylococcus aureus ATCC 43300(MIC=25µg/ml),Staphylococcus aureus ATCC 43300(MIC=100µg/ml),Staphylococcus epidermidis ATCC 12228(MIC=12.5µg/ml),Staphylococcus epidermidis ATCC 12228(MIC=12.5µg/ml),Pseudomonas aeruginosa PAO1(MIC=50µg/ml),Pseudomonas aeruginosa PAO1(MIC=50µg/ml),Pseudomonas aeruginosa(MIC=25µg/ml),Pseudomonas aeruginosa(MIC=50µg/ml),Pseudomonas aeruginosa ATCC 19660(MIC=25µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=25µg/ml)"}}}